A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)

计划入组 63 人 · 首次发布于 2024 年 6 月 24 日

Gambro AK200 ULTRA Hemodiafiltration Study

计划入组 14 人 · 首次发布于 2010 年 9 月 16 日

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

计划入组 32 人 · 首次发布于 2016 年 2 月 5 日

ANG2010

AXV201

NVD200

Anaveon Presents Positive ANV600 Clinical Data at ASCO 2026, Seeks Partners for Oncology Portfolio

Beacon Therapeutics Licenses Abeona's AAV204 Gene Therapy Platform for Retinal Disease Treatment

Aurinia Pharmaceuticals Initiates Phase Ia Trial of AUR200 for Autoimmune Diseases